Some of the nation's largest retailers are recalling infants' ibuprofen after its manufacturer found it might have higher doses of the drug than intended.

That manufacturer, New Jersey-based Tris Pharma Inc., says the recall affects three lots of its store-brand 50 mg infants' ibuprofen concentrated oral suspension.

The medicine was sold by a variety of retailers, including CVS, Family Dollar and Walmart.

"There is a remote possibility that infants, who may be more susceptible to a higher potency level of drug, and therefore may be more vulnerable to permanent NSAID-associated renal injury," Tris Pharma said in a news release. "Adverse effects that may be experienced are nausea, vomiting, epigastric pain, or more rarely, diarrhea. Tinnitus, headache and gastrointestinal bleeding are also possible adverse effects."

So far, the company says it has received no reports of infants injured as a result of taking the recalled ibuprofen.

Lot numbers affected include:


CVS: 00717024A, expires 8/19
Family Dollar: 00717024A, expires 8/19
Walmart: 00717009A, 00717015A and 00717024A, expires, respectively, 2/19, 4/19 and 8/19

If you have any of these products, return them to the store for a full refund.